Emory University Solid Biosciences Inc. Transaction History

Emory University

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.6 - $10.13 $1.37 Million - $3.03 Million	-298,887 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$7.19 - $32.37 $1.65 Million - $7.45 Million	230,173 Added 334.97%	298,887 $2.75 Million
Q4 2018 Feb 12, 2019	BUY	$21.32 - $46.34 $1.46 Million - $3.18 Million	68,714 New	68,714 $1.84 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $71.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.